Matt Carter


Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.


Matt Carter advises clients on a broad range of strategic and financial transactions, from mergers and acquisitions to divestitures, majority and minority investments, venture capital financings, and complex, contested transactions.

His clients have included public and private companies, multinational corporations, private equity sponsors, and hedge funds active across a wide spectrum of technology, infrastructure, financial services, consumer, life sciences, and agricultural sectors.


Bar Admissions

  • New York
  • California


  • Stanford University, J.D.
  • Claremont Graduate University, M.A.
  • Pomona College, B.A.
  • Represented a major hedge fund in its investment, via secondary block trade, in a NASDAQ-listed freight and logistics company
  • Represented a European financial services firm in its acquisition of a U.S.-based provider of ETF data and analytics
  • Represented a major hedge fund in its sale of a biotherapeutics-focused portfolio company to a London-listed acquirer
  • Represented an multinational infrastructure investor’s U.S. subsidiary in seven separate acquisitions of substantially all assets of a number of private aviation and engineering concerns
  • Represented a U.S. sports media fund in its creation and platform acquisition
  • Represented the founders of an international medical device company in their proposed management buyout
  • Represented a NASDAQ-listed pharmaceuticals company in a wide variety of corporate governance, shareholder proposal and SEC disclosure matters
  • Represented a sports media company in its sale of substantially all assets to a strategic acquirer